NICOX (EPA:COX) | WebDisclosure

Basculer en Français

10644	Companies
226385	Keywords
154852	Articles
119819	Press releases

Home
Companies
NICOX

PRESS RELEASE

published on 06/30/2025 at 07:30, 11 months 26 days ago

Nicox annonce que le dernier patient a terminé l’essai clinique de Phase 3 Denali sur NCX 470
Nicox annonce la fin de l'essai clinique de Phase 3 Denali sur NCX 470. Premiers résultats attendus entre mi-août et mi-septembre 2025. Autorisation de mise sur le marché aux Etats-Unis prévue pour le premier semestre 2026

Essai Clinique Pharmaceutique Nicox NCX 470 Glaucome
BRIEF

published on 06/06/2025 at 07:35, 1 year ago

Nicox Announces Shareholders’ Meeting and Ad Hoc Representative

Voting Rights Shareholders’ Meeting Euronext Growth Nicox Ad Hoc Representative
BRIEF

published on 06/06/2025 at 07:35, 1 year ago

Nicox annonce une assemblée générale des actionnaires et un représentant ad hoc

Euronext Growth Droit De Vote Assemblée Générale Des Actionnaires Nicox Représentant Ad Hoc
PRESS RELEASE

published on 06/06/2025 at 07:30, 1 year ago

Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 27, 2025 and appointment of an ad hoc representative
Nicox SA announces Ordinary and Extraordinary Shareholders' Meeting on June 27, 2025, appoints ad hoc representative. Details on agenda, proxy voting, and meeting participation

Shareholders' Meeting Proxy Voting Nicox SA Ad Hoc Representative Meeting Participation
PRESS RELEASE

published on 06/06/2025 at 07:30, 1 year ago

Nicox : Convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 27 juin 2025 et désignation d’un mandataire ad hoc
Nicox convoque une Assemblée Générale Ordinaire et Extraordinaire le 27 juin 2025, avec un mandataire ad hoc pour représenter les actionnaires défaillants

Actionnaires Assemblée Générale Ophtalmologie Nicox Mandataire Ad Hoc
BRIEF

published on 05/27/2025 at 07:35, 1 year ago

Nicox obtient jusqu'à 3 millions d'euros grâce à Kowa pour l'avancée de NCX 470

Phase 3 Nicox Hypertension Oculaire NCX 470 Kowa
BRIEF

published on 05/27/2025 at 07:35, 1 year ago

Nicox secures up to €3 million from Kowa to advance NCX 470

Ocular Hypertension Phase 3 Nicox NCX 470 Kowa
PRESS RELEASE

published on 05/27/2025 at 07:30, 1 year ago

Nicox annonce jusqu’à 3 millions d’euros de paiements d’étapes de la part de Kowa en 2025, alors que NCX 470 se prépare à entrer en essais cliniques de Phase 3 au Japon
Nicox annonce jusqu’à 3 millions d’euros de paiements d’étapes de la part de Kowa en 2025 pour le lancement d'essais cliniques de Phase 3 de NCX 470 au Japon, prolongeant ainsi leur horizon de trésorerie

Essais Cliniques Nicox Horizon De Trésorerie Kowa Paiements D'étapes
BRIEF

published on 05/14/2025 at 07:35, 1 year 1 month ago

Nicox Reports Findings from Whistler Phase 3b Glaucoma Trial

Glaucoma Nicox NCX 470 Whistler Phase 3b Intraocular Pressure
BRIEF

published on 05/14/2025 at 07:35, 1 year 1 month ago

Nicox publie les résultats de l'essai de phase 3b sur le glaucome à Whistler

Nicox NCX 470 Glaucome Whistler Phase 3b Pression Intraoculaire

Accesswire

Published on 06/26/2026 at 01:40, 8 hours 45 minutes ago

UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 10 hours 55 minutes ago

Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 11 hours 55 minutes ago

Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 12 hours 53 minutes ago

BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 18 hours 55 minutes ago

Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation

View all ACCESSWIRE

EQS Group

Published on 06/26/2026 at 10:15, 9 minutes ago

FP Markets expands its share CFD portfolio with landmark SpaceX (SPCX) listing
Published on 06/26/2026 at 10:00, 24 minutes ago

Europe and China Must Pivot from Tech Rivalry to 'Constructive Engagement' in AI Era, Warn Leaders at CEIBS Forums
Published on 06/26/2026 at 10:00, 25 minutes ago

17ème augmentation de capital sursouscrite pour l’Akara Swiss Diversity Property Fund PK
Published on 06/26/2026 at 10:00, 25 minutes ago

Oversubscribed 17th capital increase for Akara Swiss Diversity Property Fund PK
Published on 06/26/2026 at 09:59, 26 minutes ago

AGRANA finalises sale of Leopoldsdorf areal to PCS Holding

Les Echos

Published on 06/26/2026 at 07:00, 3 hours 25 minutes ago

Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 3 hours 25 minutes ago

Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 15 hours 39 minutes ago

Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 15 hours 55 minutes ago

Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 16 hours 35 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

View all LES ECHOS COMFI WIRE